Loading... (0%)

News + Events

news

3-V Biosciences to Present Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston, MA

02 November 2015

Menlo Park, California, November 2, 2015. 3-V Biosciences, Inc., a clinical-stage biopharmaceutical company developing therapeutics in oncology, announced today that it will present three abstracts at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics to be held November 5-9 in Boston, Massachusetts. Abstract information is as follows: Title: A First-In-Human Study of the…

3-V Biosciences to Present Data at the 18th ECCO – 40th ESMO European Cancer Congress in Vienna

17 September 2015

Menlo Park, California, September 17, 2015. 3-V Biosciences, Inc., a clinical-stage biopharmaceutical company developing therapeutics in oncology, announced today that it will present data from its ongoing Phase 1 clinical study at the 18th ECCO – 40th ESMO European Cancer Congress to be held September 25-29 in Vienna, Austria. The late-breaking abstract titled “Evidence of…